Arbutus Biopharma Corp (ABUS)

Cost of Revenue

$33.00K

TTM · Period ending: · USD

ABUS logo

ABUS Cost of Revenue

Latest reported$33.00K
ABUS TTM Cost of Revenue ($1.90M → $33.00K)
High-resolution chart · PNG

ABUS cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Arbutus Biopharma Corp Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
33,000
33,000
8,981,000
17,780,000
17,769,000
17,769,000
8,810,000
17,564,000
17,564,000
17,564,000
17,564,000
22,949,000
22,949,000
22,949,000
22,949,000
19,212,000
19,212,000
35,011,000
48,793,000
45,973,000
58,038,000
52,704,000
49,338,000
45,364,000
51,030,000
53,305,000
57,601,000
56,246,000
55,081,000
58,697,000
57,934,000
64,693,000
63,664,000
62,753,000
62,676,000
62,010,000
62,211,000
61,981,000
61,253,000
59,001,000
59,617,000
54,102,000
51,515,000
48,513,000
41,468,000
41,066,000
38,713,000
33,805,398
29,993,765
25,505,722
21,418,689
21,565,860
19,219,953
17,922,440
17,951,496
14,670,171
15,740,496
18,627,660
20,284,206
1,038,579,489,939
1,038,575,268,154
1,038,573,449,932
1,038,572,999,998
15,267,492
19,415,162
18,607,356
16,120,716
10,787,245
6,639,575
2,865,995
1,902,853
1,902,853
1,902,853
1,902,853
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.